◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › E › EUZ

Eckert & Ziegler SE (EUZ) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-08-16

Eckert & Ziegler SE (EUZ) operates in the Medical Devices industry and is headquartered in Berlin, Germany with about 1,100 employees. Its market capitalization is roughly €850 million. In the fiscal year ended 2025-12-31, EUZ reported €312M in revenue and €49M in net income.

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products.

Interactive charts & full statements →

EUZ Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	€312M	€296M	€246M	€222M	—
Gross Profit	€153M	€143M	€113M	€107M	—
Operating Income (EBIT)	€75M	€67M	€47M	€46M	—
Net Income	€49M	€33M	€26M	€29M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EUZ Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	€73M	€88M	€75M	€81M	€68M	—
Gross Profit	€36M	€45M	€34M	€39M	€34M	—
Operating Income (EBIT)	€16M	€26M	€15M	€18M	€16M	—
Net Income	€10M	€19M	€8M	€12M	€10M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EUZ Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(€10M)	(€1M)	(€10M)	(€10M)	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EUZ Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	—	€0M	€0M	—	—	€0M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EUZ Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	€458M	€442M	€439M	€408M	—
Total Liabilities	€204M	€217M	€215M	€194M	—

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EUZ viewer.

Other Companies in Medical Devices

6922 · Cryofocus Medtech (Shanghai) Co., Ltd. — $896 million
INMD · InMode Ltd. — $880 million
CBLL · CeriBell, Inc. — $879 million
KURN · Kuros Biosciences AG — $869 million
SIBN · SI-BONE, Inc. — $809 million
AHCO · AdaptHealth Corp. — $806 million
BBNX · Beta Bionics, Inc. — $790 million
VREX · Varex Imaging Corporation — $780 million

← EURK All “E” companies EVAC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.